SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-019253
Filing Date
2021-08-10
Accepted
2021-08-10 21:46:05
Documents
1
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3946
  Complete submission text file 0001493152-21-019253.txt   5458
Mailing Address C/O BIOPHARMX CORPORATION 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address
Krammer Anja B (Reporting) CIK: 0001418077 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39796 | Film No.: 211161761

Mailing Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129
Business Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129 (866)908-4867
Vivos Therapeutics, Inc. (Issuer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus